Novel Azaspirooxindolinone-Based PROTACs for Selective BTK Degradation and Enhanced Anticancer Activity

13 September 2024, Version 2

Abstract

Proteolysis targeting chimera (PROTAC) facilitates the degradation of specific endogenous proteins via the E3 ubiquitin ligase pathway. This study evaluates nine PROTAC derivatives of azaspirooxindolinone targeting IL-2 inducible T cell kinase (ITK) and Bruton’s Tyrosine Kinase (BTK), which are implicated in hematological malignancies, autoimmune diseases, allergies, and neuroinflammation. Among all the tested compounds, three (PROTACs 7, 14, and 25) exhibited high cytotoxicity (IC50 < 10 µM) against BTK- and ITK-positive cancer cell lines, while showing no cytotoxicity against non-cancer fibroblast cells and normal T/B-cell lymphocytes. Despite having the highest docking score of -12.1 kcal/mol, PROTAC 7 did not reduce BTK or ITK protein levels in treated cells. Similarly, PROTAC 14, with a docking score of -11.2 kcal/mol, and a high cytotoxic against RAMOS cells did not reduce BTK levels. PROTAC 25, also with a docking score of -11.2 kcal/mol, was notably effective in inducing BTK degradation in a proteasome-dependent manner, which was inhibited in the presence of bortezomib. PROTAC 25 degradation of BTK led to the inhibition of BTK phosphorylation and downstream activation of p38 in lipopolysaccharide and IgM-stimulated RAMOS cells. In conclusion, we report a PROTAC derivative (25) of azaspirooxindolinone that shows significant activity against BTK-high cells.

Keywords

Antiproliferative activity
Azaspirooxindolinone
Bruton's tyrosine kinase
Jurkat
IL-2-inducible T-cell Kinase
PROTAC
Ramos

Supplementary materials

Title
Description
Actions
Title
Supporting Data
Description
The Supporting Data contains the characterization of all compounds (1H NMR, 13C NMR, HRMS, HPLC, and FT-IR spectra), representative IC50 curves, supplementary cytotoxicity method and table, and images of full western blots.
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.